Ruxience 00069-0238
Generic: Rituximab-Pvvr
Product NDC
00069-0238- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 23, 2020
- Listing Expires
- December 31, 2027
- Application
- BLA761103
Need to source Ruxience? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rituximab | 100 mg/10mL |
Drug Class
CD20-directed Cytolytic Antibody [EPC]CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]
Packaging Options(1)
1 VIAL, SINGLE-USE in 1 CARTON (0069-0238-01) / 10 mL in 1 VIAL, SINGLE-USE